# OnCo record gallbladder-adenocarcinoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/gallbladder-adenocarcinoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "gallbladder-adenocarcinoma" ;
  schema:name "Gallbladder adenocarcinoma"@en ;
  schema:alternateName "Adenocarcinoma of the gallbladder"@en, "Non-papillary adenocarcinoma of the gallbladder"@en, "Pancreatobiliary-type gallbladder adenocarcinoma"@en ;
  schema:description "Adenocarcinoma is the usual form of gallbladder cancer, about nine in ten cases, starting in the mucus-making gland cells of the lining. Everything on the main gallbladder cancer page (causes, staging, surgery, chemotherapy with immunotherapy) is written about this type unless it says otherwise."@en ;
  schema:url <https://onco.cc/cancers/gallbladder-adenocarcinoma/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Gallbladder_cancer> ;
  schema:citation <https://www.cancerresearchuk.org/about-cancer/gallbladder-cancer/types>, <https://doi.org/10.1111/his.13975>, <https://doi.org/10.1038/s41572-022-00398-y>, <https://doi.org/10.5858/arpa.2011-0447-oa>, <https://doi.org/10.1007/s10552-025-01967-8>, <https://www.cancerresearchuk.org/about-cancer/gallbladder-cancer/stages-and-grades> ;
  onco:tag "gallbladder", "biliary", "subtype-page" ;
  onco:related <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/gallbladder-papillary-carcinoma/>, <https://onco.cc/cancers/gallbladder-mucinous-carcinoma/>, <https://onco.cc/cancers/gallbladder-adenosquamous-squamous-carcinoma/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine-cisplatin/>, <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/drugs/zanidatamab/> ;
  onco:terms <https://onco.cc/terms/tumour-grade/>, <https://onco.cc/terms/t2a-versus-t2b/>, <https://onco.cc/terms/cystic-duct-margin/>, <https://onco.cc/terms/radical-cholecystectomy/> ;
  onco:trials <https://onco.cc/trials/bilcap/>, <https://onco.cc/trials/topaz-1/>, <https://onco.cc/trials/keynote-966/> ;
  onco:standardOfCare <https://onco.cc/terms/simple-cholecystectomy/>, <https://onco.cc/terms/radical-cholecystectomy/>, <https://onco.cc/drugs/capecitabine/>, <https://onco.cc/trials/bilcap/>, <https://onco.cc/drugs/gemcitabine-cisplatin/>, <https://onco.cc/drugs/durvalumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/zanidatamab/> .